Microparticles of iron oxide (MPIOs) can be detected by MRI with high sensitivity. This has recently led to their utilization as efficient contrast agents for molecular imaging or cell tracking. We present first steps toward in vivo quantification of a targeted MPIO that is widely used for inflammation imaging. These steps include 1) relaxivities and molar susceptibility measurements on a phantom, 2) in vivo estimation of the concentration of inflammation-specific MPIOs in a mouse model of cerebrovascular inflammation and 3) acquisition of ex vivo images that validate the results obtained in vivo.
This abstract and the presentation materials are available to members only; a login is required.